newsfilter
← Latest News
GlobeNewswire·

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

TX45 is an Fc-relaxin fusion protein being evaluated in patients with Group 2 Pulmonary Hypertension (PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF), a serious condition estimated to affect over